Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Open Forum Infectious Diseases ; 8(SUPPL 1):S330-S331, 2021.
Article in English | EMBASE | ID: covidwho-1746540

ABSTRACT

Background. We conducted a follow up study on patients previously diagnosed with COVID-19 one year ago in an urban community in Paterson, New Jersey. The purpose of the study was to evaluate the socioeconomic impact of COVID-19 as well as assess for receptiveness towards COVID-19 vaccination amongst various ethnic groups. Methods. This was a prospective cohort study consisting of patients who had COVID-19 in the months of March and April of 2020. This was a single institutional study conducted at St. Joseph's Hospital in Paterson, NJ from March to April of 2021. Patients included were either male or female aged 18 years or older. Patients were contacted by telephone to participate to completed the survey. Chi-square testing and multivariable logistic regression analysis were utilized for statistical analysis. Results. Of the 170 patients enrolled in the study, the most common ethnicity was Hispanic (79/170 [46.47%]), followed by African American (46/170 [27.05%]). 83 patients were male (83/170 [48.82%]). Caucasians were the most willing to receive a COVID-19 vaccine (28/30 [93.3%]), followed by Asians (13/14 [92.8%]), Hispanics (63/78 [80.7%]) and African Americans (29/46 [63.0%]). Hispanics had the highest rate of job loss (31/79 [39.24%]), followed by African Americans (16/46 [34.7%]). Hispanics were found to be in the most financial distress (31/79 [39.2%]), followed by African Americans (17/46 [36.9%]). Hispanics and African Americans were more likely to refuse COVID-19 vaccination (p: 0.02). Hispanics were more likely to lose their jobs compared to Caucasians (odds ratio,4.456;95% CI, 1.387 to 14.312;p: 0.0121). African Americans were also more likely to lose their jobs when compared to Caucasians (odds ratio, 4.465;95% CI, 1.266 to 15.747;p: 0.0200). Conclusion. Hispanics reported the most financial distress and with nearly 40% losing their jobs, the highest in our study group. 37% of African Americans experienced job loss and financial distress following their diagnosis with COVID-19. Only 63% of African Americans and 80.7% of Hispanics were willing to get vaccinated, mostly due to lack of trust in the vaccine. Statistical analysis showed Hispanics and African Americans were more likely to lose their jobs and refuse COVID-19 vaccination following diagnosis with COVID-19.

2.
Lucrari Stiintifice, Universitatea de Stiinte Agricole Si Medicina Veterinara a Banatului, Timisoara, Seria I, Management Agricol ; 23(2):60-69, 2021.
Article in English | CAB Abstracts | ID: covidwho-1573272

ABSTRACT

The beginning of 2020 brought the whole world into a difficult situation at all levels. The motivation for the research comes from the fact that the global pandemic caused by COVID-19 has led many states to take radical decisions and many sectors have been critically affected, including tourism and agriculture. Comparing the impact of value added tax (VAT) quotas, monetary measures and accounting policies in the tourism and agriculture sector in the European Union and the comparison between COVID-19 measures taken by the top 3 European tourism countries and Romania is one of the objectives of this research. The purpose of this investigation is to study the importance of fiscal, monetary and accounting policies in tourism in Romania and to analyze the measures taken by the states with the most tourists in the European Union and Romania. This paper can also be considered as a first part of a study on the impact of COVID-19 on tourism and agriculture in which the measures taken during this period are analyzed. Another major objective is to demonstrate that tourism revenues directly impact demand for agricultural products.

3.
Chest ; 160(4):A566-A567, 2021.
Article in English | EMBASE | ID: covidwho-1458070

ABSTRACT

TOPIC: Chest Infections TYPE: Original Investigations PURPOSE: Many patients diagnosed with COVID-19 develop a post-viral syndrome commonly known as Long COVID-19. Long COVID is described as when a patient experiences persistent symptoms for more than 12 weeks after their initial infection. Recent studies have shown that patients may experience long covid for as many as 6 months after initial infection. We conducted a follow up study on patients diagnosed with COVID-19 one year ago at one of the worst affected tertiary hospitals in the state of New Jersey. METHODS: This was a prospective cohort study consisting of patients with a confirmed positive COVID-19 test by PCR in the months of March and April of 2020 in the St. Joseph’s University Hospital network. Individuals who were either admitted to the hospital or tested positive in the outpatient setting with Sars- CoV2 were included in the study. Patients under 18 years of age or those with cognitive impairment or inability to complete the survey were excluded. Informed consent was taken over the telephone. The participants completed a comprehensive questionnaire including sociodemographic information and a review of systems to evaluate for persistent symptoms they have experienced over the past year directly due to COVID-19. All patient identifying information was de-identified in compliance with HIPAA rules and regulations. RESULTS: There were 91 inpatients ( 91/173 [52.6%]) and 82 outpatients (82/173 [47.4%]) with a mean age of 51.5. The most common ethnicities were Hispanic (80/173 [46.24%]) African American (48/173 [27.74%]), Caucasian (32/173 [18.49%]) and the most common comorbidities were hypertension (68/173 [39.5%]), obesity (45/173 [26.9%]) and diabetes (33/173 [19.1%]). There were 91 inpatients ( 91/173 [52.6%]) and 82 outpatients (82/173 [47.4%]), of which 85 were male (85/173 [49.42%]). Overall 83 patients (47.9%) still experienced at least one persistent symptom after initial infection. The most commonly reported symptoms were shortness of breath (44/173 [25.4%]), fatigue (43/173 [21%]), anxiety (36/173 [20.8%]), difficulty focusing/brain fog (32/173 [18.5%]), body aches (32/173 [18.5%]), headaches (29/173 [16.8%]), memory loss (25/173 [14.5%]), cough (23/173 [13.3%]), depression (22/173 [12.7%]), chest pain (19/173 [11%]), palpitations (15/173 [8.7%]), lightheadedness (15/173 [8.7%]), runny nose (12/173 [6.9%]) and loss of taste (11/173 [6.4%]). CONCLUSIONS: In our patient population nearly half of all patients (47.9%) still experienced at least one symptom 12 months after their initial infection. In both patient populations the most common persistent symptoms were shortness of breath, fatigue, anxiety and difficulty focusing/brain fog. The risk factors and pathophysiology of long covid remain unknown, highlighting the importance of further research into the topics. CLINICAL IMPLICATIONS: Nearly half of our patient population still experienced at least one symptom from their COVID-19 infection after one year. This further suggests that infection with COVID-19 may carry a risk of developing long term and possibly permanent sequelae from the virus. As more patients continue to be infected with COVID-19 and subsequently develop long covid, a public health crisis may be looming in the future. This highlights the need for continued public education on COVID-19 as well as the critical importance of widespread vaccination across the world to end the pandemic. DISCLOSURES: No relevant relationships by Polina Aron, source=Web Response No relevant relationships by Hamdallah Ashkar, source=Web Response No relevant relationships by Sohail Chaudhry, source=Web Response No relevant relationships by Arslan Chaudhry, source=Web Response No relevant relationships by Beenish Faheem, source=Web Response No relevant relationships by Alisa Farokhian, source=Web Response No relevant relationships by George Horani, source=Web Response No relevant relationships by Humberto Jimenez, source=Web Response No relevant relationships by Christina Kmiecik, source=Web Response No relevant relationships by Patrick Michael, source=Web Response No relevant relationships by Christopher Millet, source=Web Response No relevant relationships by Spandana Narvaneni, source=Web Response No relevant relationships by Sherif Roman, source=Web Response No relevant relationships by Fady Shafeek, source=Web Response No relevant relationships by Yezin Shamoon, source=Web Response No relevant relationships by Jin Suh, source=Web Response

4.
Int J Environ Res Public Health ; 18(6)2021 03 18.
Article in English | MEDLINE | ID: covidwho-1145617

ABSTRACT

Heavy goods vehicle (HGV) driving is recognised as a highly hazardous occupation due to the long periods of sedentary behaviour, low levels of physical activity and unhealthy food options when working. These risk factors combine with shift work and concomitant irregular sleep patterns to increase the prevalence of fatigue. Fatigue is closely linked with stress and, subsequently, poor physiological and psychological health. In parallel, a wealth of evidence has demonstrated the health and wellbeing benefits of spending time in nature. Here, we sought to examine whether spending time in nature was associated with lower levels of fatigue, anxiety and depression in HGV drivers. 89 long-distance drivers (98.9% male, mean ± SD age: 51.0 ± 9 years, body mass index: 29.8 ± 4.7 kg/m2) participating in a wider health promotion programme reported time spent in nature (during and before the Covid-19 pandemic) and symptoms of occupational fatigue, depression and anxiety. After controlling for covariates, truck drivers who visited nature at least once a week exhibited 16% less chronic fatigue prior to the pandemic, and 23% less chronic fatigue and 20% less acute fatigue during the pandemic. No significant differences were observed for either anxiety or depression. As fatigue has a range of physical and mental health sequelae, we propose that increased exposure to natural settings may make a valuable contribution to interventions to promote the health and wellbeing of this underserved group.


Subject(s)
Automobile Driving , COVID-19 , Adult , Female , Humans , Male , Middle Aged , Motor Vehicles , Pandemics , SARS-CoV-2 , United Kingdom/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL